Last update:

Clinical genetics news

Researchers find two understudied 'forever chemicals' raise liver cancer risk

A first-of-its-kind USC study links two little-studied "forever chemicals" to liver cancer, with the greatest risk in those already genetically susceptible to fatty liver disease. The study, published in Environmental Health ...

Targeting immune overactivity in Down syndrome shows promise in phase 2 clinical trial

In a first-of-its-kind clinical trial, researchers at the Linda Crnic Institute for Down Syndrome (Crnic Institute) at the University of Colorado Anschutz found that a medication targeting immune overactivity in people with ...

How research paved the way for progress in a rare form of ALS

An experimental ALS drug that grew out of basic and clinical research at Columbia University's Vagelos College of Physicians and Surgeons may soon become available for patients with a rare and aggressive form of the disease.

RNA switch lets drugs control gene therapy protein production

Bioengineers at the University of California San Diego have developed a technology that allows drugs to control when cells produce therapeutic proteins, which could potentially make gene therapies safer and more adaptable ...